Phase II Trial of VEGF Trap in Patients With Previously Treated Metastatic Colorectal Cancer
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Aflibercept (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Apr 2009 Planned end date (June 2008) added as reported by ClinicalTrials.gov.
- 10 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Jan 2008 Status changed from suspended to recruiting.